The 340B PATIENTS Act of 2025 aims to ensure drug accessibility under the 340B drug discount program.

The 340B PATIENTS Act of 2025 amends the Public Health Service Act to clarify that drug manufacturers must offer discount pricing for drugs purchased by covered entities, regardless of the manner or location in which the drug is dispensed. This includes drugs dispensed through contract pharmacies. The bill also prohibits manufacturers from placing conditions on covered entities' ability to purchase and use covered outpatient drugs at discounted pricing.

The 340B PATIENTS Act of 2025 aims to ensure drug accessibility under the 340B drug discount program.

The 340B PATIENTS Act of 2025 amends the Public Health Service Act to clarify that drug manufacturers must offer discount pricing for drugs purchased by covered entities, regardless of the manner or location in which the drug is dispensed. This includes drugs dispensed through contract pharmacies. The bill also prohibits manufacturers from placing conditions on covered entities' ability to purchase and use covered outpatient drugs at discounted pricing.